Research Directory

US selects first drugs for price negotiations

Read more

European Commission highlights access, supply in pharma proposal

Read more

New era for drug pricing in US

Read more

Integrated product development for ATMPs

Read more

The shift towards value-based pricing for medicines

Read more

Non-governmental drug assessments in the US

Read more

Mandatory joint EU assessments are coming at last

Read more

The case for value-based pricing

Read more

Real-world evidence - the new healthcare currency

Read more

The next step for EU health technology assessment

Read more